Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Chantilly › NPI 1447296272
Lab

Quest Diagnostics Nichols Institute, INC.

Quest Diagnostics Nichols Institute, INC. was paid $46.91M by Medicaid between Jan 2018 and Dec 2024, across 436 billing codes. Its largest line is 87799, — 11% of everything it billed.

33Billing provider infoQUEST DIAGNOSTICS NICHOLS INSTITUTE, INC.
CHANTILLY, VA 20151
33aNPI1447296272assigned 06/21/2006
33bProvider typeClinical Medical Laboratory
28Total paid$46.91M
24GClaims2,407,863
24DCodes billed436
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Virginia

Rank by total paid#3 of 78
Median peer was paid$37K
This provider vs. median1,273×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official TIMMERMAN, LEAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018362,300$8.17M
2019439,658$9.37M
2020384,466$7.12M
2021403,395$7.68M
2022297,841$5.89M
2023285,153$4.83M
2024incomplete235,050$3.86M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87799 11% 154,602 93,736 $5.19M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 8.1% 6,687 6,629 $3.81M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 7.5% 102,762 95,943 $3.54M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 7.3% 116,475 83,581 $3.45M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 6.2% 101,422 74,401 $2.91M
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 6.1% 10,811 10,071 $2.87M
87512 4.8% 97,779 89,456 $2.24M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 3.4% 102,095 95,258 $1.61M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 2.8% 103,151 94,524 $1.30M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2.7% 103,053 94,450 $1.29M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.5% 22,927 17,353 $1.16M
87902 2.4% 15,183 14,367 $1.14M
424 more codes
82652 2.1% 65,765 $990K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 2.0% 8,661 $955K
84403 1.8% 110,858 $861K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.3% 46,534 $612K
87536 1.0% 10,923 $488K
84402 <1% 51,780 $459K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 13,470 $309K
88185 <1% 2,199 $305K
84425 <1% 32,661 $295K
84445 <1% 11,429 $284K
84270 <1% 37,294 $270K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 10,858 $256K
86003 <1% 8,693 $252K
86146 <1% 11,387 $236K
87522 Neg quan hep c or qual rna <1% 7,828 $217K
83498 <1% 16,585 $215K
83921 <1% 19,187 $211K
87529 <1% 11,286 $205K
86696 <1% 24,205 $193K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 4,670 $192K
87563 <1% 9,851 $181K
83516 <1% 18,512 $177K
84207 <1% 13,094 $175K
83520 <1% 25,266 $170K
86780 <1% 17,508 $145K
86695 <1% 23,472 $135K
86360 <1% 5,929 $135K
86235 <1% 4,669 $125K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 605 $125K
82024 <1% 5,697 $117K
83655 <1% 13,512 $110K
83021 <1% 8,336 $107K
84590 <1% 14,961 $104K
87535 <1% 4,743 $102K
80177 <1% 11,337 $100K
82088 <1% 6,485 $99K
83013 <1% 2,337 $94K
85246 <1% 7,297 $94K
86147 <1% 4,656 $94K
84443 Thyroid stimulating hormone (TSH) <1% 8,592 $91K
86812 <1% 7,293 $91K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 5,015 $89K
80061 Lipid panel <1% 9,870 $89K
87481 <1% 1,201 $87K
86255 <1% 13,486 $86K
85245 <1% 6,580 $86K
82784 <1% 10,646 $81K
80159 <1% 11,026 $81K
84630 <1% 14,012 $80K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 4,937 $79K
87497 <1% 3,074 $77K
80175 <1% 9,274 $76K
83835 <1% 6,781 $76K
86666 <1% 6,442 $76K
85240 <1% 7,012 $75K
81382 <1% 1,350 $74K
81381 <1% 2,588 $74K
84244 <1% 6,393 $71K
80053 Comprehensive metabolic panel <1% 9,837 $71K
80183 <1% 7,629 $66K
85247 <1% 4,627 $64K
82728 <1% 7,248 $63K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,658 $63K
86359 <1% 5,445 $62K
83880 <1% 3,578 $62K
86376 <1% 6,882 $61K
86787 <1% 7,141 $61K
81376 <1% 1,354 $61K
80348 <1% 8,377 $58K
86355 <1% 4,940 $55K
80050 General health panel <1% 1,679 $54K
82542 <1% 5,383 $52K
86341 <1% 4,364 $51K
86611 <1% 4,255 $49K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 9,781 $49K
86803 <1% 4,799 $48K
80349 <1% 6,502 $47K
84446 <1% 5,349 $47K
81206 <1% 989 $47K
80361 <1% 4,936 $46K
86480 <1% 1,433 $46K
80346 <1% 5,480 $45K
83036 Hemoglobin; glycosylated (A1C) <1% 7,889 $42K
85730 <1% 9,968 $42K
86021 <1% 4,244 $41K
82525 <1% 5,448 $41K
83020 <1% 5,035 $40K
86160 <1% 3,992 $40K
85613 <1% 6,042 $40K
36415 Collection of venous blood by venipuncture <1% 42,902 $40K
82787 <1% 2,873 $39K
82384 <1% 2,739 $39K
87338 <1% 3,630 $39K
82610 <1% 4,102 $38K
88189 <1% 1,638 $38K
83735 <1% 9,256 $37K
87517 <1% 1,371 $36K
81513 <1% 526 $36K
88184 <1% 2,139 $36K
86753 <1% 5,956 $35K
80373 <1% 10,246 $35K
84439 <1% 6,087 $34K
86357 <1% 3,351 $34K
83970 <1% 1,259 $34K
82040 <1% 19,544 $33K
84482 <1% 5,928 $32K
82164 <1% 4,221 $31K
86231 <1% 5,705 $31K
82607 <1% 3,501 $30K
86038 <1% 4,869 $30K
85303 <1% 2,869 $30K
86671 <1% 4,378 $29K
86738 <1% 2,534 $29K
86769 <1% 785 $29K
82239 <1% 2,692 $29K
80354 <1% 5,132 $29K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 519 $28K
85306 <1% 2,522 $28K
86774 <1% 3,171 $28K
82785 <1% 2,571 $26K
80365 <1% 3,340 $26K
86481 <1% 631 $25K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 518 $25K
86800 <1% 2,858 $25K
81329 <1% 1,476 $24K
86162 <1% 2,879 $24K
86592 <1% 8,094 $24K
86665 <1% 1,018 $23K
81240 <1% 631 $23K
82955 <1% 4,401 $23K
80355 <1% 3,219 $23K
80323 <1% 2,057 $23K
82085 <1% 4,323 $23K
80324 <1% 3,008 $22K
83695 <1% 3,160 $22K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 422 $22K
83003 <1% 698 $22K
82570 <1% 7,345 $21K
86200 <1% 2,823 $21K
86008 <1% 1,246 $20K
80164 <1% 2,287 $20K
81241 <1% 704 $20K
86225 <1% 2,614 $20K
87340 <1% 2,637 $20K
81270 <1% 1,963 $20K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,795 $20K
86148 <1% 4,241 $20K
88262 <1% 262 $19K
84432 <1% 1,963 $19K
86361 <1% 1,394 $19K
84255 <1% 1,336 $19K
80165 <1% 2,320 $19K
82627 <1% 1,349 $18K
86015 <1% 2,914 $18K
86364 <1% 2,453 $18K
85300 <1% 2,015 $18K
82397 <1% 2,043 $18K
80321 <1% 2,429 $18K
81374 <1% 673 $18K
84305 <1% 1,384 $17K
86648 <1% 1,980 $17K
83090 <1% 1,958 $17K
86140 <1% 5,425 $17K
82523 <1% 2,642 $17K
85041 <1% 7,872 $16K
88230 <1% 284 $16K
82670 <1% 845 $16K
85598 <1% 1,464 $16K
85018 <1% 8,989 $16K
87088 <1% 2,392 $16K
80353 <1% 2,595 $14K
86757 <1% 886 $14K
82175 <1% 1,349 $14K
83825 <1% 1,626 $14K
80201 <1% 1,712 $14K
86340 <1% 1,647 $13K
83001 <1% 1,098 $13K
80503 <1% 1,217 $13K
82985 <1% 2,527 $13K
81229 <1% 26 $12K
83519 <1% 1,284 $12K
83002 <1% 1,012 $12K
80359 <1% 2,322 $12K
85597 <1% 1,079 $12K
80358 <1% 2,769 $12K
80366 <1% 1,311 $12K
84202 <1% 1,989 $11K
85014 <1% 6,530 $11K
84080 <1% 2,142 $11K
86036 <1% 1,589 $11K
86381 <1% 1,217 $11K
87521 Neg quan hep c or qual rna <1% 458 $11K
81403 <1% 261 $11K
84597 <1% 1,248 $11K
87186 <1% 2,344 $11K
82105 <1% 795 $10K
80299 <1% 894 $10K
80368 <1% 7,985 $9K
86664 <1% 726 $9K
82746 <1% 1,277 $9K
81219 <1% 665 $9K
82705 <1% 3,085 $9K
82043 <1% 2,041 $9K
86762 <1% 843 $9K
82157 <1% 488 $9K
85305 <1% 914 $9K
82552 <1% 1,804 $9K
81207 <1% 237 $8K
80360 <1% 1,070 $8K
81256 <1% 299 $8K
83540 <1% 1,917 $8K
84702 <1% 903 $8K
84480 <1% 1,037 $8K
80356 <1% 1,047 $8K
86161 <1% 1,041 $8K
82390 <1% 1,185 $8K
83625 <1% 1,072 $8K
85302 <1% 816 $8K
84075 <1% 3,855 $8K
82550 <1% 2,082 $8K
83525 <1% 1,100 $8K
82172 <1% 1,076 $8K
83550 <1% 1,606 $8K
87081 <1% 1,776 $8K
83497 <1% 1,066 $8K
80156 <1% 781 $7K
86707 <1% 716 $7K
86747 <1% 454 $7K
86317 <1% 997 $7K
88142 <1% 482 $7K
80069 <1% 1,375 $7K
87077 <1% 1,427 $7K
81279 <1% 640 $7K
86039 <1% 1,078 $7K
88341 <1% 44 $7K
86706 <1% 950 $7K
84153 <1% 453 $7K
80372 <1% 876 $6K
84146 <1% 512 $6K
80364 <1% 858 $6K
80074 <1% 209 $6K
86334 <1% 308 $6K
86765 <1% 728 $6K
86735 <1% 739 $6K
84460 <1% 1,740 $6K
82977 <1% 1,287 $6K
80362 <1% 2,604 $6K
82677 <1% 344 $6K
80337 <1% 721 $6K
80320 <1% 897 $6K
86684 <1% 567 $5K
80048 Basic metabolic panel (calcium, ionized) <1% 933 $5K
80370 <1% 702 $5K
80338 <1% 755 $5K
87350 <1% 656 $5K
80367 <1% 706 $5K
84252 <1% 421 $5K
84156 <1% 2,338 $5K
80326 <1% 702 $5K
81401 <1% 532 $5K
86704 <1% 529 $5K
80344 <1% 696 $5K
80340 <1% 703 $5K
83993 <1% 455 $5K
84165 <1% 622 $5K
87209 <1% 611 $5K
80345 <1% 885 $5K
80197 <1% 540 $4K
80357 <1% 836 $4K
87480 <1% 329 $4K
87510 <1% 329 $4K
87660 <1% 329 $4K
83992 <1% 762 $4K
87177 <1% 753 $4K
80333 <1% 706 $4K
81001 <1% 2,202 $4K
82103 <1% 451 $4K
83615 <1% 1,235 $4K
84100 <1% 1,422 $4K
86708 <1% 436 $4K
84436 <1% 1,084 $4K
88342 <1% 109 $4K
80369 <1% 7,115 $4K
86336 <1% 359 $4K
81339 <1% 574 $4K
85027 <1% 676 $4K
85610 <1% 1,304 $4K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 161 $3K
80377 <1% 693 $3K
84376 <1% 889 $3K
86663 <1% 273 $3K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 108 $3K
86632 <1% 746 $3K
82747 <1% 261 $3K
87070 <1% 439 $3K
86256 <1% 451 $3K
82657 <1% 187 $3K
88377 <1% 48 $3K
87625 <1% 144 $3K
84681 <1% 255 $3K
82310 <1% 842 $3K
80371 <1% 361 $3K
83014 <1% 548 $3K
86631 <1% 264 $3K
82375 <1% 285 $3K
84155 <1% 996 $2K
86215 <1% 360 $2K
88271 <1% 75 $2K
82180 <1% 403 $2K
84378 <1% 293 $2K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 19 $2K
80375 <1% 148 $2K
82248 <1% 664 $2K
86606 <1% 131 $2K
80157 <1% 249 $2K
83690 <1% 548 $2K
85670 <1% 518 $2K
85045 <1% 843 $2K
86431 <1% 548 $2K
80330 <1% 699 $2K
86617 <1% 107 $2K
81402 <1% 109 $2K
80076 <1% 314 $2K
82540 <1% 616 $2K
83605 <1% 263 $2K
84450 <1% 498 $2K
80500 <1% 807 $2K
87254 <1% 135 $2K
81291 <1% 430 $2K
87449 <1% 271 $2K
81479 Unlisted molecular pathology procedure <1% 680 $1K
84260 <1% 122 $1K
84154 <1% 98 $1K
84145 <1% 94 $1K
82608 <1% 150 $1K
87110 <1% 74 $1K
83785 <1% 68 $1K
82672 <1% 82 $1K
80186 <1% 88 $1K
83521 <1% 57 $982.95
86618 <1% 75 $973.17
83018 <1% 59 $971.26
84591 <1% 295 $960.57
82150 <1% 290 $924.28
86644 <1% 98 $914.56
80195 <1% 87 $846.92
85307 <1% 72 $845.71
87329 <1% 105 $843.50
84550 <1% 287 $769.12
80352 <1% 148 $742.35
82565 <1% 222 $730.44
82668 <1% 64 $729.13
82495 <1% 55 $706.26
83883 <1% 87 $702.84
80335 <1% 134 $683.22
86705 <1% 74 $629.92
84442 <1% 74 $620.15
82533 <1% 65 $616.77
85549 <1% 53 $569.65
85652 <1% 265 $550.80
82308 <1% 43 $535.81
85651 <1% 244 $499.20
84466 <1% 57 $490.61
82941 <1% 50 $487.81
87140 <1% 123 $486.17
82642 <1% 39 $483.62
83874 <1% 60 $479.81
80171 <1% 43 $467.08
86794 <1% 40 $460.90
87147 <1% 65 $437.66
86710 <1% 31 $404.44
82330 <1% 43 $380.71
82300 <1% 29 $379.88
86850 <1% 94 $377.65
83789 <1% 33 $331.38
82947 <1% 128 $325.63
84481 <1% 30 $323.55
80180 <1% 28 $316.53
86788 <1% 28 $312.15
85230 <1% 25 $306.50
81005 <1% 246 $293.45
86698 <1% 19 $291.61
82247 <1% 86 $287.36
88112 <1% 16 $283.13
86258 <1% 26 $280.65
86300 <1% 24 $261.40
86789 <1% 26 $258.10
80168 <1% 26 $249.24
84520 <1% 65 $243.25
82232 <1% 32 $234.83
82595 <1% 60 $231.46
83986 <1% 90 $197.12
86645 <1% 28 $191.40
86901 <1% 61 $170.43
86900 <1% 61 $170.43
84478 <1% 46 $161.17
86778 <1% 13 $156.92
82465 <1% 54 $152.63
86777 <1% 12 $149.86
86790 <1% 24 $139.43
83945 <1% 16 $136.63
87109 <1% 14 $131.61
82373 <1% 12 $122.30
81003 <1% 89 $113.72
87324 <1% 17 $113.11
82104 <1% 16 $105.70
87168 <1% 94 $98.57
84479 <1% 73 $93.82
85301 <1% 14 $91.06
86702 <1% 12 $89.17
85004 <1% 17 $85.83
86593 <1% 28 $85.13
86701 <1% 12 $62.71
87101 <1% 13 $60.87
85049 <1% 16 $57.20
87205 <1% 17 $55.51
80178 <1% 13 $53.64
82950 <1% 12 $52.25
86403 <1% 12 $49.35
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 60 $48.94
85048 <1% 17 $34.09
99001 <1% 38 $6.38
81327 0% 209 $0.00
81243 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTIMMERMAN, LEAH (SR. VICE PRESIDENT)
Parent organizationQUEST DIAGNOSTICS INCORPORATED
Same official

Other billing entities under TIMMERMAN, LEAH

Full network →
ProviderLocationPaid
Unilab CorporationWest Hills, CA$668.50M
Quest Diagnostics IncorporatedClifton, NJ$637.74M
Quest Diagnostics LLC IlWood Dale, IL$429.84M
Quest Diagnostics Clinical Laboratories INCIrving, TX$276.76M
Labone LLCLenexa, KS$212.28M
Quest Diagnostics Clinical Laboratories INCTucker, GA$211.13M
Quest Diagnostics Clinical Laboratories INCMiramar, FL$197.58M
Labone of Ohio INCCincinnati, OH$167.17M
Unilab CorporationSacramento, CA$141.24M
Quest Diagnostics Incorporated MDBaltimore, MD$121.81M
Quest Diagnostics IncorporatedLas Vegas, NV$59.32M
Quest Diagnostics LLC IlSchaumburg, IL$50.71M
Quest Diagnostics Clinical Laboratories INCTampa, FL$49.99M
Quest Diagnostics Nichols InstituteSan Juan Capistrano, CA$39.93M
Quest Diagnostics Clinical Laboratories INCNorristown, PA$22.72M
Specialty Laboratories INCWest Hills, CA$16.76M
Quest Diagnostics Clinical Laboratories INCDenver, CO$14.27M
Quest Diagnostics Clinical Laboratories INCHouston, TX$8.76M
Med Fusion, LLCLewisville, TX$4.17M
Quest Diagnostics Clinical Laboratories INCMaryland Heights, MO$2.98M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.